Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893): Difference between revisions
From MaRDI portal
Removed claims |
Changed an Item |
||
| Property / author | |||
| Property / author: Richard M. Simon / rank | |||
Normal rank | |||
| Property / author | |||
| Property / author: Harry S. Wieand / rank | |||
Normal rank | |||
Revision as of 20:49, 22 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials |
scientific article |
Statements
Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (English)
0 references
30 June 1999
0 references
conditional independence
0 references
exponential components
0 references
colorectal adjuvant clinical trials
0 references
